PA
MTRX icon

PharVision Advisers’s Matrix Service MTRX Stock Holding History

PharVision Advisers’s Portfolio MTRX Stock Details MTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,826
Closed -$419K – 448
2025
Q4 		$419K Buy
35,826
+24,064
+205% +$302K 0.21% 101
2025
Q3 		$154K Buy
+11,762
New +$167K 0.09% 569

Other funds holding MTRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $368M AUM 42.67% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's MTRX Position: Q1 2026 in Review

PharVision Advisers sold out of Matrix Service (MTRX) in Q1 2026, closing a stake of 35,826 shares — an estimated $419K sold.

PharVision Advisers first reported a position in MTRX in Q3 2025 and held it in 2 quarters. The position peaked at $419K in Q4 2025. 144 funds tracked by Wall St. Rank hold MTRX as of Q1 2026.

  • PharVision Advisers reported no remaining Matrix Service position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 35,826 Matrix Service shares in Q1 2026, an estimated $419K.
  • PharVision Advisers first reported a position in Matrix Service in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Matrix Service position peaked at $419K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held Matrix Service as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.